FDA Approved: AMYVID — Supplemental Application (Eli Lilly and Company)

View source ↗

Summary

The FDA approved a supplemental application for AMYVID (florbetapir F 18) from Eli Lilly and Company. The submission status indicates approval (AP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• AMYVID (Florbetapir F-18)

Snippet

SUPPL AP for AMYVID (FLORBETAPIR F 18)